Logo image of SAFX

XCF GLOBAL INC-A (SAFX) Stock Fundamental Analysis

USA - NASDAQ:SAFX - US98400U1034 - Common Stock

1.28 USD
0 (0%)
Last: 9/16/2025, 8:00:02 PM
1.3 USD
+0.02 (+1.56%)
After Hours: 9/16/2025, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, SAFX scores 1 out of 10 in our fundamental rating. SAFX was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of SAFX have multiple concerns. SAFX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SAFX had negative earnings in the past year.
SAFX Yearly Net Income VS EBIT VS OCF VS FCFSAFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

With a Return On Assets value of -38.07%, SAFX is not doing good in the industry: 93.81% of the companies in the same industry are doing better.
SAFX has a Return On Equity of -128.29%. This is amonst the worse of the industry: SAFX underperforms 89.05% of its industry peers.
Industry RankSector Rank
ROA -38.07%
ROE -128.29%
ROIC N/A
ROA(3y)-7.82%
ROA(5y)N/A
ROE(3y)-25.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SAFX Yearly ROA, ROE, ROICSAFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

SAFX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SAFX Yearly Profit, Operating, Gross MarginsSAFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, SAFX has less shares outstanding
SAFX has a worse debt/assets ratio than last year.
SAFX Yearly Shares OutstandingSAFX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
SAFX Yearly Total Debt VS Total AssetsSAFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 8.68 indicates that SAFX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.68, SAFX belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
SAFX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, SAFX belongs to the top of the industry, outperforming 81.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 8.68
ROIC/WACCN/A
WACCN/A
SAFX Yearly LT Debt VS Equity VS FCFSAFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

SAFX has a Current Ratio of 0.00. This is a bad value and indicates that SAFX is not financially healthy enough and could expect problems in meeting its short term obligations.
SAFX has a Current ratio of 0.00. This is amonst the worse of the industry: SAFX underperforms 96.67% of its industry peers.
A Quick Ratio of 0.00 indicates that SAFX may have some problems paying its short term obligations.
The Quick ratio of SAFX (0.00) is worse than 96.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
SAFX Yearly Current Assets VS Current LiabilitesSAFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for SAFX have decreased strongly by -2245.37% in the last year.
EPS 1Y (TTM)-2245.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SAFX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SAFX Price Earnings VS Forward Price EarningsSAFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAFX Per share dataSAFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SAFX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XCF GLOBAL INC-A

NASDAQ:SAFX (9/16/2025, 8:00:02 PM)

After market: 1.3 +0.02 (+1.56%)

1.28

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap191.05M
AnalystsN/A
Price TargetN/A
Short Float %0.48%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 46.47
P/tB 46.47
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.07%
ROE -128.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.82%
ROA(5y)N/A
ROE(3y)-25.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 8.68
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2245.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-228.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.12%
OCF growth 3YN/A
OCF growth 5YN/A